Analysis of Reports on Adverse Drug Reactions Related to Herbal Medicinal Products and Herbal Supplements in the Netherlands Received by the National Pharmacovigilance Centre Lareb
Introduction The inclusion of herbal medicinal products and herbal supplements in pharmacovigilance systems is important because a systematic approach of collecting and analyzing adverse drug reactions related to these products will help practitioners, patients, and regulators to gain more knowledge...
Gespeichert in:
Veröffentlicht in: | Drug safety 2022-06, Vol.45 (6), p.651-661 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 661 |
---|---|
container_issue | 6 |
container_start_page | 651 |
container_title | Drug safety |
container_volume | 45 |
creator | van Hunsel, Florence P. A. M. van der Kooi, Djurre van de Koppel, Sonja Kroes, Burt H. Woerdenbag, Herman J. |
description | Introduction
The inclusion of herbal medicinal products and herbal supplements in pharmacovigilance systems is important because a systematic approach of collecting and analyzing adverse drug reactions related to these products will help practitioners, patients, and regulators to gain more knowledge and prevent harm.
Objective
We aimed to categorize the adverse drug reaction reports on herbal medicinal products and herbal supplements submitted to the Pharmacovigilance Centre Lareb between 1991 and February 2021 on the basis of their regulatory status, herbs included, and adverse drug reactions involved.
Methods
We categorized products on the basis of their registration status and herbal ingredients. The products were then categorized according to the Herbal Anatomical Therapeutic Chemical Classification System. We used descriptive statistics in Microsoft Excel 2019. Pivot tables were used for the analysis and presentation of the data.
Results
Until February 2021, a total of 789 reports of herbal medicinal products and herbal supplements were received by Lareb. In these reports, a total of 823 herbal products were labeled as suspect. These products caused a total of 1727 adverse drug reactions. Of the 823 products, 229 were registered as a medicine, and 594 were on the market as a herbal supplement. Of the 823 herbal products, 522 reports concerned single-herb products, 256 reports concerned combination products, 27 reports concerned vitamin products containing herbal ingredients, and 18 reports concerned product issues. Approximately 15% of reports concerned serious adverse drug reactions, and adulterated products harbored a high risk of causing serious adverse drug reactions.
Conclusions
Analysis of the herbal medicinal products and herbal supplements in the Dutch pharmacovigilance database revealed a variety of suspected herbal ingredients. The reports provide insight into the variety of herbal products used in the Netherlands and the adverse reactions associated with their use. Pharmacovigilance of herbal products is essential to ensure their safe use. |
doi_str_mv | 10.1007/s40264-022-01180-5 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2678519229</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2678519229</sourcerecordid><originalsourceid>FETCH-LOGICAL-c419t-da3bf80b530ed237aaa24a83c4e7dd19585321bb4b02a6c59cad8ca85d9e839f3</originalsourceid><addsrcrecordid>eNp9kdtu1DAQhi1ERbeFF-ACWeI6xYc4sS9Xy6FIS0EcrqOxPdmmysbBTlba9-oD4iUt3PXGHv3zzzcj_YS85uyKM1a_SyUTVVkwIQrGuWaFekZWnNem4KYUz8kqq2WhDK_OyUVKd4wxLSr9gpxLVTFda7ki9-sB-mPqEg0t_Y5jiFMuB7r2B4wJ6fs477IOburCkHLVw4SeToFeY7TQ0y_oO9dlCP0Wg59dHofBP3Z_zOPY4x6HLHcDnW6R3mB-Y59NJ5zD7pB59rj04LTmxLqFuAcXDt2uy1aHdJMZEekWItqX5KyFPuGrh_-S_Pr44efmuth-_fR5s94WruRmKjxI22pmlWTohawBQJSgpSux9p4bpZUU3NrSMgGVU8aB1w608ga1NK28JG8X7hjD7xnT1NyFOeb7UiOqWituhDDZJRaXiyGliG0zxm4P8dhw1pyCapagmhxU8zeoRuWhNw_o2e7R_xt5TCYb5GJIuTXsMP7f_QT2DyuUoYs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2678519229</pqid></control><display><type>article</type><title>Analysis of Reports on Adverse Drug Reactions Related to Herbal Medicinal Products and Herbal Supplements in the Netherlands Received by the National Pharmacovigilance Centre Lareb</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>van Hunsel, Florence P. A. M. ; van der Kooi, Djurre ; van de Koppel, Sonja ; Kroes, Burt H. ; Woerdenbag, Herman J.</creator><creatorcontrib>van Hunsel, Florence P. A. M. ; van der Kooi, Djurre ; van de Koppel, Sonja ; Kroes, Burt H. ; Woerdenbag, Herman J.</creatorcontrib><description>Introduction
The inclusion of herbal medicinal products and herbal supplements in pharmacovigilance systems is important because a systematic approach of collecting and analyzing adverse drug reactions related to these products will help practitioners, patients, and regulators to gain more knowledge and prevent harm.
Objective
We aimed to categorize the adverse drug reaction reports on herbal medicinal products and herbal supplements submitted to the Pharmacovigilance Centre Lareb between 1991 and February 2021 on the basis of their regulatory status, herbs included, and adverse drug reactions involved.
Methods
We categorized products on the basis of their registration status and herbal ingredients. The products were then categorized according to the Herbal Anatomical Therapeutic Chemical Classification System. We used descriptive statistics in Microsoft Excel 2019. Pivot tables were used for the analysis and presentation of the data.
Results
Until February 2021, a total of 789 reports of herbal medicinal products and herbal supplements were received by Lareb. In these reports, a total of 823 herbal products were labeled as suspect. These products caused a total of 1727 adverse drug reactions. Of the 823 products, 229 were registered as a medicine, and 594 were on the market as a herbal supplement. Of the 823 herbal products, 522 reports concerned single-herb products, 256 reports concerned combination products, 27 reports concerned vitamin products containing herbal ingredients, and 18 reports concerned product issues. Approximately 15% of reports concerned serious adverse drug reactions, and adulterated products harbored a high risk of causing serious adverse drug reactions.
Conclusions
Analysis of the herbal medicinal products and herbal supplements in the Dutch pharmacovigilance database revealed a variety of suspected herbal ingredients. The reports provide insight into the variety of herbal products used in the Netherlands and the adverse reactions associated with their use. Pharmacovigilance of herbal products is essential to ensure their safe use.</description><identifier>ISSN: 0114-5916</identifier><identifier>EISSN: 1179-1942</identifier><identifier>DOI: 10.1007/s40264-022-01180-5</identifier><identifier>PMID: 35608783</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Adverse Drug Reaction Reporting Systems ; Commodities ; Consumers ; Dietary supplements ; Dietary Supplements - adverse effects ; Drug Safety and Pharmacovigilance ; Drug stores ; Drug-Related Side Effects and Adverse Reactions - epidemiology ; Drug-Related Side Effects and Adverse Reactions - etiology ; EU directives ; Food ; Herbal medicine ; Herbs ; Humans ; Ingredients ; International organizations ; Marketing ; Medicine ; Medicine & Public Health ; Netherlands ; Original Research Article ; Pharmacology ; Pharmacology/Toxicology ; Pharmacovigilance ; Pharmacy ; Plants, Medicinal ; Reporting requirements ; Side effects ; Statistical analysis</subject><ispartof>Drug safety, 2022-06, Vol.45 (6), p.651-661</ispartof><rights>The Author(s), under exclusive licence to Springer Nature Switzerland AG 2022</rights><rights>2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.</rights><rights>Copyright Springer Nature B.V. Jun 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c419t-da3bf80b530ed237aaa24a83c4e7dd19585321bb4b02a6c59cad8ca85d9e839f3</citedby><cites>FETCH-LOGICAL-c419t-da3bf80b530ed237aaa24a83c4e7dd19585321bb4b02a6c59cad8ca85d9e839f3</cites><orcidid>0000-0001-8965-3224 ; 0000-0002-9450-5880</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s40264-022-01180-5$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s40264-022-01180-5$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35608783$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>van Hunsel, Florence P. A. M.</creatorcontrib><creatorcontrib>van der Kooi, Djurre</creatorcontrib><creatorcontrib>van de Koppel, Sonja</creatorcontrib><creatorcontrib>Kroes, Burt H.</creatorcontrib><creatorcontrib>Woerdenbag, Herman J.</creatorcontrib><title>Analysis of Reports on Adverse Drug Reactions Related to Herbal Medicinal Products and Herbal Supplements in the Netherlands Received by the National Pharmacovigilance Centre Lareb</title><title>Drug safety</title><addtitle>Drug Saf</addtitle><addtitle>Drug Saf</addtitle><description>Introduction
The inclusion of herbal medicinal products and herbal supplements in pharmacovigilance systems is important because a systematic approach of collecting and analyzing adverse drug reactions related to these products will help practitioners, patients, and regulators to gain more knowledge and prevent harm.
Objective
We aimed to categorize the adverse drug reaction reports on herbal medicinal products and herbal supplements submitted to the Pharmacovigilance Centre Lareb between 1991 and February 2021 on the basis of their regulatory status, herbs included, and adverse drug reactions involved.
Methods
We categorized products on the basis of their registration status and herbal ingredients. The products were then categorized according to the Herbal Anatomical Therapeutic Chemical Classification System. We used descriptive statistics in Microsoft Excel 2019. Pivot tables were used for the analysis and presentation of the data.
Results
Until February 2021, a total of 789 reports of herbal medicinal products and herbal supplements were received by Lareb. In these reports, a total of 823 herbal products were labeled as suspect. These products caused a total of 1727 adverse drug reactions. Of the 823 products, 229 were registered as a medicine, and 594 were on the market as a herbal supplement. Of the 823 herbal products, 522 reports concerned single-herb products, 256 reports concerned combination products, 27 reports concerned vitamin products containing herbal ingredients, and 18 reports concerned product issues. Approximately 15% of reports concerned serious adverse drug reactions, and adulterated products harbored a high risk of causing serious adverse drug reactions.
Conclusions
Analysis of the herbal medicinal products and herbal supplements in the Dutch pharmacovigilance database revealed a variety of suspected herbal ingredients. The reports provide insight into the variety of herbal products used in the Netherlands and the adverse reactions associated with their use. Pharmacovigilance of herbal products is essential to ensure their safe use.</description><subject>Adverse Drug Reaction Reporting Systems</subject><subject>Commodities</subject><subject>Consumers</subject><subject>Dietary supplements</subject><subject>Dietary Supplements - adverse effects</subject><subject>Drug Safety and Pharmacovigilance</subject><subject>Drug stores</subject><subject>Drug-Related Side Effects and Adverse Reactions - epidemiology</subject><subject>Drug-Related Side Effects and Adverse Reactions - etiology</subject><subject>EU directives</subject><subject>Food</subject><subject>Herbal medicine</subject><subject>Herbs</subject><subject>Humans</subject><subject>Ingredients</subject><subject>International organizations</subject><subject>Marketing</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Netherlands</subject><subject>Original Research Article</subject><subject>Pharmacology</subject><subject>Pharmacology/Toxicology</subject><subject>Pharmacovigilance</subject><subject>Pharmacy</subject><subject>Plants, Medicinal</subject><subject>Reporting requirements</subject><subject>Side effects</subject><subject>Statistical analysis</subject><issn>0114-5916</issn><issn>1179-1942</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp9kdtu1DAQhi1ERbeFF-ACWeI6xYc4sS9Xy6FIS0EcrqOxPdmmysbBTlba9-oD4iUt3PXGHv3zzzcj_YS85uyKM1a_SyUTVVkwIQrGuWaFekZWnNem4KYUz8kqq2WhDK_OyUVKd4wxLSr9gpxLVTFda7ki9-sB-mPqEg0t_Y5jiFMuB7r2B4wJ6fs477IOburCkHLVw4SeToFeY7TQ0y_oO9dlCP0Wg59dHofBP3Z_zOPY4x6HLHcDnW6R3mB-Y59NJ5zD7pB59rj04LTmxLqFuAcXDt2uy1aHdJMZEekWItqX5KyFPuGrh_-S_Pr44efmuth-_fR5s94WruRmKjxI22pmlWTohawBQJSgpSux9p4bpZUU3NrSMgGVU8aB1w608ga1NK28JG8X7hjD7xnT1NyFOeb7UiOqWituhDDZJRaXiyGliG0zxm4P8dhw1pyCapagmhxU8zeoRuWhNw_o2e7R_xt5TCYb5GJIuTXsMP7f_QT2DyuUoYs</recordid><startdate>20220601</startdate><enddate>20220601</enddate><creator>van Hunsel, Florence P. A. M.</creator><creator>van der Kooi, Djurre</creator><creator>van de Koppel, Sonja</creator><creator>Kroes, Burt H.</creator><creator>Woerdenbag, Herman J.</creator><general>Springer International Publishing</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>4T-</scope><scope>7RV</scope><scope>7T2</scope><scope>7TK</scope><scope>7U7</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><orcidid>https://orcid.org/0000-0001-8965-3224</orcidid><orcidid>https://orcid.org/0000-0002-9450-5880</orcidid></search><sort><creationdate>20220601</creationdate><title>Analysis of Reports on Adverse Drug Reactions Related to Herbal Medicinal Products and Herbal Supplements in the Netherlands Received by the National Pharmacovigilance Centre Lareb</title><author>van Hunsel, Florence P. A. M. ; van der Kooi, Djurre ; van de Koppel, Sonja ; Kroes, Burt H. ; Woerdenbag, Herman J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c419t-da3bf80b530ed237aaa24a83c4e7dd19585321bb4b02a6c59cad8ca85d9e839f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Adverse Drug Reaction Reporting Systems</topic><topic>Commodities</topic><topic>Consumers</topic><topic>Dietary supplements</topic><topic>Dietary Supplements - adverse effects</topic><topic>Drug Safety and Pharmacovigilance</topic><topic>Drug stores</topic><topic>Drug-Related Side Effects and Adverse Reactions - epidemiology</topic><topic>Drug-Related Side Effects and Adverse Reactions - etiology</topic><topic>EU directives</topic><topic>Food</topic><topic>Herbal medicine</topic><topic>Herbs</topic><topic>Humans</topic><topic>Ingredients</topic><topic>International organizations</topic><topic>Marketing</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Netherlands</topic><topic>Original Research Article</topic><topic>Pharmacology</topic><topic>Pharmacology/Toxicology</topic><topic>Pharmacovigilance</topic><topic>Pharmacy</topic><topic>Plants, Medicinal</topic><topic>Reporting requirements</topic><topic>Side effects</topic><topic>Statistical analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>van Hunsel, Florence P. A. M.</creatorcontrib><creatorcontrib>van der Kooi, Djurre</creatorcontrib><creatorcontrib>van de Koppel, Sonja</creatorcontrib><creatorcontrib>Kroes, Burt H.</creatorcontrib><creatorcontrib>Woerdenbag, Herman J.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Docstoc</collection><collection>Nursing & Allied Health Database</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Drug safety</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>van Hunsel, Florence P. A. M.</au><au>van der Kooi, Djurre</au><au>van de Koppel, Sonja</au><au>Kroes, Burt H.</au><au>Woerdenbag, Herman J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Analysis of Reports on Adverse Drug Reactions Related to Herbal Medicinal Products and Herbal Supplements in the Netherlands Received by the National Pharmacovigilance Centre Lareb</atitle><jtitle>Drug safety</jtitle><stitle>Drug Saf</stitle><addtitle>Drug Saf</addtitle><date>2022-06-01</date><risdate>2022</risdate><volume>45</volume><issue>6</issue><spage>651</spage><epage>661</epage><pages>651-661</pages><issn>0114-5916</issn><eissn>1179-1942</eissn><abstract>Introduction
The inclusion of herbal medicinal products and herbal supplements in pharmacovigilance systems is important because a systematic approach of collecting and analyzing adverse drug reactions related to these products will help practitioners, patients, and regulators to gain more knowledge and prevent harm.
Objective
We aimed to categorize the adverse drug reaction reports on herbal medicinal products and herbal supplements submitted to the Pharmacovigilance Centre Lareb between 1991 and February 2021 on the basis of their regulatory status, herbs included, and adverse drug reactions involved.
Methods
We categorized products on the basis of their registration status and herbal ingredients. The products were then categorized according to the Herbal Anatomical Therapeutic Chemical Classification System. We used descriptive statistics in Microsoft Excel 2019. Pivot tables were used for the analysis and presentation of the data.
Results
Until February 2021, a total of 789 reports of herbal medicinal products and herbal supplements were received by Lareb. In these reports, a total of 823 herbal products were labeled as suspect. These products caused a total of 1727 adverse drug reactions. Of the 823 products, 229 were registered as a medicine, and 594 were on the market as a herbal supplement. Of the 823 herbal products, 522 reports concerned single-herb products, 256 reports concerned combination products, 27 reports concerned vitamin products containing herbal ingredients, and 18 reports concerned product issues. Approximately 15% of reports concerned serious adverse drug reactions, and adulterated products harbored a high risk of causing serious adverse drug reactions.
Conclusions
Analysis of the herbal medicinal products and herbal supplements in the Dutch pharmacovigilance database revealed a variety of suspected herbal ingredients. The reports provide insight into the variety of herbal products used in the Netherlands and the adverse reactions associated with their use. Pharmacovigilance of herbal products is essential to ensure their safe use.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>35608783</pmid><doi>10.1007/s40264-022-01180-5</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0001-8965-3224</orcidid><orcidid>https://orcid.org/0000-0002-9450-5880</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0114-5916 |
ispartof | Drug safety, 2022-06, Vol.45 (6), p.651-661 |
issn | 0114-5916 1179-1942 |
language | eng |
recordid | cdi_proquest_journals_2678519229 |
source | MEDLINE; Springer Nature - Complete Springer Journals |
subjects | Adverse Drug Reaction Reporting Systems Commodities Consumers Dietary supplements Dietary Supplements - adverse effects Drug Safety and Pharmacovigilance Drug stores Drug-Related Side Effects and Adverse Reactions - epidemiology Drug-Related Side Effects and Adverse Reactions - etiology EU directives Food Herbal medicine Herbs Humans Ingredients International organizations Marketing Medicine Medicine & Public Health Netherlands Original Research Article Pharmacology Pharmacology/Toxicology Pharmacovigilance Pharmacy Plants, Medicinal Reporting requirements Side effects Statistical analysis |
title | Analysis of Reports on Adverse Drug Reactions Related to Herbal Medicinal Products and Herbal Supplements in the Netherlands Received by the National Pharmacovigilance Centre Lareb |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T10%3A13%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Analysis%20of%20Reports%20on%20Adverse%20Drug%20Reactions%20Related%20to%20Herbal%20Medicinal%20Products%20and%20Herbal%20Supplements%20in%20the%20Netherlands%20Received%20by%20the%20National%20Pharmacovigilance%20Centre%20Lareb&rft.jtitle=Drug%20safety&rft.au=van%20Hunsel,%20Florence%20P.%20A.%20M.&rft.date=2022-06-01&rft.volume=45&rft.issue=6&rft.spage=651&rft.epage=661&rft.pages=651-661&rft.issn=0114-5916&rft.eissn=1179-1942&rft_id=info:doi/10.1007/s40264-022-01180-5&rft_dat=%3Cproquest_cross%3E2678519229%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2678519229&rft_id=info:pmid/35608783&rfr_iscdi=true |